Government Advises Against Cough Syrups for Children Under Two
The Union health ministry has issued a precautionary advisory amid ongoing investigations into recent reports of child deaths linked to cough syrups. Parents are being urged not to administer cough syrups to children under two years of age until investigators determine the exact cause. While laboratory tests on some samples did not detect dangerous solvents, officials say the root cause remains unclear and the precautionary advice remains in place to ensure child safety.
Recent Incidents and Public Response
Two major areas—Madhya Pradesh and Rajasthan—have seen distressing cases that fueled social media chatter about the safety of cough syrups. In Madhya Pradesh’s Chhindwara district, nine children died within a short span after experiencing kidney failure. In Rajasthan’s Sikar district, two children reportedly died from organ failure. Authorities noted that affected families had given cough syrups prior to the onset of symptoms. Specifically in Madhya Pradesh, reports indicate that five of the nine affected children had used a syrup marketed as Coldref, and one child had used Nextro Syrup. These developments prompted a broader review of products circulating in the market.
Laboratory Findings and Regulatory Response
The health ministry states that tests on several cough syrup samples did not reveal the presence of diethylene glycol (DEG) or ethylene glycol (EG), both of which have historically been associated with serious toxicity in certain contaminated products. The Central Drugs Standard Control Organisation (CDSCO) and the Madhya Pradesh State Food and Drug Administration (SFDA) have corroborated these findings. Despite the reassuring test results, regulatory authorities in Madhya Pradesh have suspended sales of some cough syrups as a precaution while additional batches are re-tested and traced to determine any potential links or risk factors.
Current Guidance for Parents and Caregivers
Until the investigation concludes and more data become available, the health ministry recommends avoiding cough syrups for children under two. Parents are advised to consult a pediatrician for fever, cold, or cough and to adhere strictly to prescribed dosing if medicines are prescribed. It is essential not to mix multiple cough or fever syrups and to avoid giving medicines intended for older children without professional guidance. Non-pharmacological measures, such as proper hydration, humidified air, rest, and managing fever with age-appropriate care, can help while the child recovers. Seek urgent medical care if a child shows signs of breathing difficulty, dehydration, persistent high fever, or lethargy.
What Parents Can Do Right Now
Practical steps for families include: (1) Refrain from giving over-the-counter cough syrups to children under two unless advised by a pediatrician. (2) Use only medicines prescribed for the child’s age and health profile. (3) Read labels carefully, avoid giving multiple syrups simultaneously, and store medicines out of reach. (4) Keep a symptom-and-medication log to share with healthcare providers. (5) Favor non-drug comfort measures when appropriate and follow up with a doctor for ongoing symptoms.
Where to Find Reliable Information
Official briefings from the Union health ministry, CDSCO, and state FDA offices are the most reliable sources. Authorities emphasize avoiding rumors on social media and await complete results from ongoing investigations. The goal is to protect children while ensuring that legitimate medicines remain accessible for those who genuinely need them.
